News >

ASCO Calls for Drug Pricing Reforms

Tony Hagen @oncobiz
Published: Wednesday, Jul 19, 2017

As rumors circulate in Washington, DC that President Donald Trump is weighing a set of measures to control rising drug costs, ASCO, the nation’s largest group of oncologists, has called for efforts to reach a consensus on drug value to ensure affordability and access for patients and spur manufacturers to work harder on bringing innovative medicines to market.

Although it may seem that pharmaceutical companies have control of the market and can charge what they like, Polite said that this cannot continue forever. “The manufacturers understand that they have a target on them and that either they come to the table and try to come up with prices that are reasonable or they’re going to have solutions imposed on them at some point.”
Kumar H, Fojo T, Mailankody S. An appraisal of clinically meaningful outcomes guidelines for oncology clinical trials. JAMA Oncol. 2016;2(9):1238-1240.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication